- Find a Doctor
- Medical Services
- Patients & Visitors
- Classes & Events
- Health Library
- Why Choose Sharp?
G6PD deficiency is the lack of glucose-6-phosphate dehydrogenase (an enzyme present in red blood cells) in the blood, which can cause a type of anemia known as hemolytic anemia. Red blood cells carry oxygen in the body and G6PD protects these cells from natural oxygen chemicals that may build up when you have a fever or take certain medications. If there are too many of these chemicals, they can destroy the red blood cells, causing hemolytic anemia. G6PD deficiency is inherited - people are born with the deficiency.
Hemolytic anemia is a disorder in which the red blood cells are destroyed faster than the bone marrow can produce them.
The following are the most common symptoms of hemolytic anemia. However, each individual may experience symptoms differently. Symptoms may include:
The symptoms of hemolytic anemia may resemble other blood disorders or medical problems. Always consult your physician for a diagnosis.
Certain medicines can cause natural oxygen chemicals to build up in the body. Persons with G6PD deficiency cannot protect their red blood cells against the buildup of oxygen chemicals, and the blood cells are destroyed, causing anemia. Therefore, persons with G6PD deficiency need to avoid exposing themselves to certain medicines, such as aspirin (acetylsalicylic acid), certain antibiotics used to treat infections, fava beans, and moth balls.
G6PD deficiency is inherited by a gene on the X chromosome. Chromosomes are the structures in our cells which contain our genes; genes code for all of our traits such as eye color and blood type. All humans have 46 chromosomes, or 23 pairs; the last pair determines gender: females have two X chromosomes, while males have one X and one Y chromosome. G6PD deficiency is inherited from females who carry one copy of the gene on one of their X chromosomes, to half of their sons. Sons who receive the gene have G6PD deficiency, and daughters who receive the gene are carriers (who generally do not show any symptoms). Sons and daughters who do not receive the gene are unaffected.
Certain ethnic groups have an increased incidence of G6PD deficiency than others. G6PD deficiency is seen in about 10 percent of African-American males in the US, and is also common in persons from the Mediterranean area or Asia. The severity of G6PD deficiency differs among different populations. In the most common form in the African-American population, the deficiency is mild and the hemolysis (destruction of re blood cells) affects primarily older red blood cells. In Caucasians, G6PD deficiency tends to be more serious, as even young red blood cells are affected.
G6PD deficiency can be diagnosed by a simple blood test. If your ancestors come from an area where G6PD deficiency is common, or if you have family history of G6PD deficiency or unknown anemia, you should consult your physician about having this blood test.
In most cases, G6PD deficiency does not cause problems for an individual, unless they are exposed to medications or foods which may damage their blood cells. Persons with G6PD deficiency can tolerate small amounts of these exposures, depending on the specific defect present in the gene. Specific treatment for G6PD deficiency anemia will be determined by your physician based on:
Treatment may include: